Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
about
Different infusion durations for preventing platinum-induced hearing loss in children with cancerMedical interventions for the prevention of platinum-induced hearing loss in children with cancerMedical interventions for the prevention of platinum-induced hearing loss in children with cancerPlatinum-induced hearing loss after treatment for childhood cancerDifferent infusion durations for preventing platinum-induced hearing loss in children with cancerMedical interventions for the prevention of platinum-induced hearing loss in children with cancerDifferent infusion durations for preventing platinum-induced hearing loss in children with cancerPlatinum-induced hearing loss after treatment for childhood cancerUsing germline genomics to individualize pediatric cancer treatmentsTime-frequency analysis of transient-evoked otoacoustic emissions in children exposed to carboplatin chemotherapyScreening for chemicals that affect hair cell death and survival in the zebrafish lateral lineCarboplatin-associated ototoxicity in children with retinoblastoma.Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology GroupHair cell toxicity in anti-cancer drugs: evaluating an anti-cancer drug library for independent and synergistic toxic effects on hair cells using the zebrafish lateral lineNanocarriers for delivery of platinum anticancer drugs.OTOTOXIC EFFECTS OF CARBOPLATIN IN ORGANOTYPIC CULTURES IN CHINCHILLAS AND RATSAuditory late effects of childhood cancer therapy: a report from the Children's Oncology GroupCommon variants in ACYP2 influence susceptibility to cisplatin-induced hearing lossIncidence of platinum-induced ototoxicity in pediatric patients in Quebec.Neurological complications following treatment of children with brain tumors.Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcomaN-acetylcysteine and N-nitroarginine methyl ester attenuate Carboplatin-induced ototoxicity in dissociated spiral ganglion neuron cultures.Ototoxicity and cancer therapy.Hypersensitivity to Carboplatin in Children with Malignancy.Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.Design and synthesis of coumarin-based organoselenium as a new hit for myeloprotection and synergistic therapeutic efficacy in adjuvant therapy.Sensorineural hearing loss following induction chemotherapy plus concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma.
P2860
Q24193767-693F71EE-9A16-4E68-B2C1-C79C0F7925A8Q24194929-64AD3F4C-A200-4E04-AA99-DCE6AC04BB66Q24197812-34B15962-A780-4830-A880-611332D26E29Q24197838-5689AC02-6EE9-4BA4-B800-73035DB505FDQ24202129-344BBE67-7E9A-49D7-A176-A1968470E776Q24236069-EED2E7DB-FFBD-4C52-955A-4A8C18948AF4Q26470492-439C82FA-AF8B-41B0-8BF3-574F997C0F46Q26470526-7AC91C84-7044-4CDE-9C5F-8DB33C9D52E5Q27003261-5E0E6030-DFE0-4F5A-BA35-B7C87B24D095Q30444977-6029A9C4-0DC5-4D7F-9010-77CE8AB150E2Q30454013-159D9AE0-E1D9-4DA2-A2C2-679A53214AFEQ30513911-2D7EF23C-1D4A-482D-91D2-319F762DE241Q30544354-CE418CFA-D569-403D-A873-B96517741B5CQ33922193-1172D225-78E7-48C1-8418-8E0DC491B438Q33952689-C251B3AD-F2F8-4D43-867C-3A770BE12180Q34338695-151ED180-B3F4-4A95-B7CD-F16A82DF080AQ34925061-A1D37D23-5C7C-4A2C-B993-EAD6D6C8C97CQ35019735-6E161085-F61E-40F9-BCFC-8FC1C59C5B54Q35172741-A38E01C0-909C-438A-88B4-782D07F93B53Q35197338-A806A015-5389-4743-A122-60920DB58A0EQ36729469-56832512-0D9C-4067-A4C0-9A9EA90ED428Q37366864-F36402F7-0D74-458E-AC2B-EECB109CEA98Q38475475-9AEAA86C-B457-433C-8C50-F29CBA868F14Q38727368-77978B84-ACCC-47E1-8889-108E920FD0EBQ38817913-88872EFF-F15C-447E-992A-24AB6CFA5E94Q38964704-44699911-8619-4278-9374-4E483E9991F5Q47547216-B39D0B48-23C0-4A19-BFE4-9CA7241C7939Q50352357-003D45D6-FC0E-4035-AC6C-09C20D7FFEF5
P2860
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
@en
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
@nl
type
label
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
@en
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
@nl
prefLabel
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
@en
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
@nl
P2093
P1476
Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens.
@en
P2093
Allison A King
Catherine M Albert
Jennifer B Dean
Roanne Karzon
Robert J Hayashi
Susan S Hayashi
P304
P356
10.1097/MPH.0B013E31815D1D83
P577
2008-02-01T00:00:00Z